Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Celldex Therapeutics (CLDX) Q2 2019 Earnings
CLDX
7
May
Confirmed
Q3 2018
Q4 2018
Q1 2019
Q2 2019
-2.22
-1.68
-1.14
-0.6
Details
Expected EPS
-1.14
Actual EPS
-1.4
Surprise EPS
-0.26
Surprise Percent
+22.81%
Description
Celldex Therapeutics (CLDX) has reported earnings of -1.4 per share for Q2 2019.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login